Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration

Authors not listed

Instituto de Olhos de Goiania · 2005

Abstract

To report the short term anatomic and visual acuity response after intravitreal injection of bevacizumab (Avastin, Roche, Rio de Janeiro, Brazil) in patients with choroidal neovascularization secondary to age-related macular degeneration.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-15 MST

Cite this

APA
Anonymous. (2005). Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration. <em>Instituto de Olhos de Goiania</em>. https://clinicaltrials.gov/study/NCT00556348
Vancouver
Anonymous. Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration. Instituto de Olhos de Goiania. 2005.
BibTeX
@misc{anon2005Intrav, title = {Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration}, author = {Anonymous}, journal = {Instituto de Olhos de Goiania}, year = {2005}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings